Glucose variability patterns for precision nutrition in diabetes

The GLUCOTYPES project aims to identify early glycaemic patterns and their dietary influences using advanced technologies to develop precision nutrition strategies for Type 2 diabetes prevention and management.

Subsidie
€ 3.988.206
2024

Projectdetails

Introduction

Type 2 diabetes (T2D) has emerged as a global epidemic, impacting 1 in 10 people worldwide and causing over 114,000 deaths annually in Europe. Despite extensive research, understanding the pathogenic mechanisms driving distinct disease subtypes and how diet influences glucose homeostasis has remained elusive.

Knowledge Gap

This knowledge gap leaves individuals with or at high risk of T2D without effective prevention or control strategies, urging a paradigm shift in our approach.

Project Overview

The GLUCOTYPES project brings together leading experts in various fields from five European countries to tackle this challenge. The areas of expertise include:

  • Nutrition
  • Metabolic diseases
  • Glycobiology
  • Gut microbiome
  • Epidemiology
  • Machine learning

Strategy

Our strategy capitalizes on advancements in wearable technologies, molecular biology, and bioinformatics. We propose to leverage high-temporal continuous glucose monitor data to identify patterns of early glycaemic alterations, a concept we refer to as glucotypes, which forms the core hypothesis of our research program.

Methodology

Circulating and adipose tissue glycoproteomics profiling will be used to gain molecular insights into glucotypes. Machine learning algorithms will be applied to investigate the intersection between diet and glucotypes on clinical outcomes. This will help us gain mechanistic insights into how diet and gut microbiome influence glucose homeostasis in specific glucotypes.

Clinical Study

The knowledge derived from these activities will inform a proof-of-concept precision nutrition clinical study to test the efficacy of a precision-based diet on cardiometabolic outcomes. Additionally, we aim to identify markers of beneficial responses to diet.

Conclusion

In doing so, GLUCOTYPES will come closer to understanding the divergent mechanisms that influence early glycaemic alterations and how specific diets could ameliorate these alterations. Our work will establish a foundational yet comprehensive scientific groundwork to inform future precision diabetes nutrition strategies to prevent and improve the lives of all people affected by the disease.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.988.206
Totale projectbegroting€ 3.988.206

Tijdlijn

Startdatum1-10-2024
Einddatum30-9-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • KOBENHAVNS UNIVERSITETpenvoerder
  • WEIZMANN INSTITUTE OF SCIENCE
  • UNIVERSITEIT MAASTRICHT
  • UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
  • ACADEMISCH ZIEKENHUIS LEIDEN
  • INTERNATIONAL LIFE SCIENCES INSTITUTE EUROPEAN BRANCH AISBL

Land(en)

DenmarkIsraelNetherlandsSpainBelgium

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

Linking Intestinal Bacteria and Host Metabolism to Tackle Type 2 Diabetes with Novel Food

DiBaN aims to develop advanced platforms for testing novel insect-based foods to prevent intestinal dysbiosis and Type 2 diabetes, integrating AI for personalized nutritional interventions.

€ 3.999.222
EIC Pathfinder

Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention

This project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses.

€ 3.765.840
EIC Pathfinder

Precision Nutrition to optimize immune response for metabolic health

NUTRIMMUNE investigates the impact of precision nutrition on immune responses in obesity-related NCDs, aiming to establish dietary recommendations through multi-omics analysis and intervention studies.

€ 4.318.432

Vergelijkbare projecten uit andere regelingen

ERC Proof of...

GenomeDia: a personalized medicine tool for diabetes

The project aims to develop a genetic interpretation tool to subcategorize young diabetes patients, enhancing treatment by leveraging findings from whole genome sequencing.

€ 150.000
ERC Proof of...

Pharmacoepigenetics for precision medicine in type 2 diabetes

PROCEED aims to develop and commercialize blood-based epigenetic markers to predict metformin response in Type 2 diabetes patients, enhancing personalized therapy and clinical decision-making.

€ 150.000
ERC Consolid...

Altered brain-periphery crosstalk as a key pathomechanism for high-risk phenotypes in humans

This project aims to elucidate the role of altered brain-periphery communication in identifying high-risk diabetes phenotypes to enhance prevention and treatment strategies.

€ 1.999.838
ERC Proof of...

Listening to Silence: The First Blood Test for Risk of Individuals at Prophylactic Time Windows to Develop Type 2 Diabetes Mellitus

This project aims to develop a clinical test using novel epigenetic biomarkers to predict Type 2 Diabetes risk in non-diabetic individuals, enabling early preventive treatments.

€ 150.000
ERC Advanced...

Circadian Control of Systemic Metabolism in Physiology and Type 2 Diabetes

This project aims to uncover how synchronizing energetic stressors with circadian rhythms can improve metabolism and inform new treatments for type 2 diabetes.

€ 2.500.000